Entrada Therapeutics Inc
NASDAQ:TRDA
Wall Street
Price Targets
TRDA Price Targets Summary
Entrada Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for TRDA is 21.42 USD with a low forecast of 20.2 USD and a high forecast of 23.1 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TRDA's stock price target?
Price Target
21.42
USD
According to Wall Street analysts, the average 1-year price target for TRDA is 21.42 USD with a low forecast of 20.2 USD and a high forecast of 23.1 USD.
What is Entrada Therapeutics Inc's Revenue forecast?
Projected CAGR
-31%
The compound annual growth rate of Entrada Therapeutics Inc's revenue for the next 3 years is -31%.